Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands.
- DOI
- 10.1016/j.vaccine.2026.129030
- Published
- 2026 Sep 17
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.129030,
title = {Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands.},
author = {Huiberts AJ and Eggink D and de Gier B and Karens T and de Melker HE and Hahné SJM and Grobbee DE and van de Wijgert JHHM and van den Hof S and Knol MJ},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.129030},
url = {https://doi.org/10.1016/j.vaccine.2026.129030}
}RIS
TY - JOUR TI - Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands. AU - Huiberts AJ AU - Eggink D AU - de Gier B AU - Karens T AU - de Melker HE AU - Hahné SJM AU - Grobbee DE AU - van de Wijgert JHHM AU - van den Hof S AU - Knol MJ PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2026.129030 UR - https://doi.org/10.1016/j.vaccine.2026.129030 ER -
APA
AJ, H., D, E., B, D. G., T, K., HE, D. M., SJM, H., DE, G., JHHM, V. D. W., S, V. D. H., & MJ, K. (2026). Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.129030
Source records
- pubmed · retrieved 2026-09-26T01:36:46.580Z